A randomized, open-label, comparative, two-period crossover trial on preference, efficacy, and safety profiles of a prefilled, disposable pen with lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to increase adherence.
CONCLUSIONS: The use of U-200 lispro might improve treatment adherence and metabolic control.
PMID: 29564932 [PubMed - as supplied by publisher]
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Insulin | Men | Study